Sino Biopharmaceutical Ltd (1177.HK)
1177.HK on Hong Kong Stock
7.54HKD
24 Sep 2018
7.54HKD
24 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
HK$7.54
HK$7.54
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
59,490,582
59,490,582
52-wk High
HK$13.93
HK$13.93
52-wk Low
HK$5.31
HK$5.31
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.08 | December | 26 Sep 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 9 | 10 | 7 | 8 |
| (2) OUTPERFORM | 5 | 5 | 6 | 6 |
| (3) HOLD | 4 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 2 | 1 | 1 | 1 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.10 | 1.90 | 2.06 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 3 | 5,771.16 | 5,988.27 | 5,389.21 | -- |
| Quarter Ending Dec-18 | 3 | 5,418.36 | 5,610.19 | 5,168.89 | -- |
| Year Ending Dec-18 | 22 | 20,151.80 | 22,311.00 | 15,922.70 | 16,744.10 |
| Year Ending Dec-19 | 22 | 24,245.00 | 28,275.00 | 17,937.30 | 18,636.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 4 | 0.08 | 0.08 | 0.07 | 0.05 |
| Quarter Ending Dec-18 | 4 | 0.05 | 0.06 | 0.03 | 0.03 |
| Year Ending Dec-18 | 23 | 0.23 | 0.28 | 0.20 | 0.19 |
| Year Ending Dec-19 | 23 | 0.28 | 0.32 | 0.22 | 0.21 |
| LT Growth Rate (%) | 2 | 20.07 | 29.80 | 10.34 | 16.99 |
Historical Surprises
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 5,092.05 | 5,072.62 | 19.44 | 0.38 |
| Quarter Ending Mar-18 | 5,155.39 | 4,652.61 | 502.78 | 9.75 |
| Quarter Ending Dec-17 | 3,522.68 | 3,372.57 | 150.10 | 4.26 |
| Quarter Ending Sep-17 | 4,276.97 | 3,963.87 | 313.10 | 7.32 |
| Quarter Ending Jun-17 | 3,659.97 | 3,471.62 | 188.35 | 5.15 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | 0.05 | 0.05 | 0.00 | 0.00 |
| Quarter Ending Mar-18 | 0.07 | 0.07 | 0.00 | 4.21 |
| Quarter Ending Dec-17 | 0.04 | 0.03 | 0.01 | 20.82 |
| Quarter Ending Sep-17 | 0.05 | 0.06 | 0.01 | 24.85 |
| Quarter Ending Jun-17 | 0.04 | 0.04 | 0.01 | 13.96 |
Consensus Estimates Trend
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 5,771.16 | 5,771.16 | 5,662.61 | 5,662.61 | -- |
| Quarter Ending Dec-18 | 5,418.36 | 5,418.36 | 5,322.44 | 5,322.44 | -- |
| Year Ending Dec-18 | 20,151.80 | 20,161.80 | 20,147.00 | 20,320.10 | 16,744.10 |
| Year Ending Dec-19 | 24,245.00 | 24,269.60 | 24,110.90 | 24,246.50 | 18,636.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 0.08 | 0.08 | 0.08 | 0.07 | 0.05 |
| Quarter Ending Dec-18 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 |
| Year Ending Dec-18 | 0.23 | 0.23 | 0.24 | 0.23 | 0.19 |
| Year Ending Dec-19 | 0.28 | 0.28 | 0.28 | 0.28 | 0.21 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 1 | 3 | 2 |
| Year Ending Dec-19 | 0 | 1 | 3 | 2 |
| Earnings | ||||
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 1 | 3 |
| Year Ending Dec-19 | 0 | 1 | 2 | 2 |
Earnings vs. 
Estimates- China stocks retreat as trade war fears persist; Hang Seng flat
- China stocks fall as investors fear trade war escalation
- BRIEF-Sino Biopharmaceutical Gets Approval From China FDA To Register Unit's Drug
- BRIEF-Sino Biopharmaceutical Says Compound Sodium Acetate Ringer's Injection Gets Drug Registration Approvals
- BRIEF-Sino Biopharmaceutical Announces Proposed Bonus Issue Of Shares